I am horrified to read that the latest group being targeted as possible recipients of Gardasil are pregnant women.
Markab Algedi writes that the University of Alabama at Birmingham along with vaccine producer Merck plan to trial Gardasil 9 on postpartum mothers. The women who agree to be part of the trial will be between the ages of 16 and 26, and receive the vaccine immediately after having their children at the UAB hospital.
Here is the part of the summary of the trial as described on the ClinicalTrials.gov website. The trial will start in June 2018 with an estimated enrollment of 200 mothers.
Due to low HPV vaccine uptake in the US, innovative approaches to vaccinating vulnerable populations are necessary in order to maximize the cancer prevention potential of this vaccine. The puerperium is a time period when women are engaged in the healthcare system and have almost universal access to affordable health care. Two prior studies have shown that postpartum HPV vaccination is acceptable to patients, and high rates of vaccination were achieved in these primarily Hispanic populations. However, data show that the immune response in young women is less robust than in adolescents, and no studies have examined immunogenicity in postpartum women specifically. We propose an HPV vaccination pilot study in women who receive postpartum care at University of Alabama at Birmingham (UAB) hospital. We will examine the acceptability, uptake and immunogenicity of the vaccine in the postpartum setting.
The most frequently reported reactions manifest as autoimmune disorders such as arthritis, vasculitis, systemic lupus erythematosus (SLE) and neurological diseases such as encephalopathy, neuropathy, and seizure disorders. But other bodily systems are affected with increasing reports of premature ovarian failure and infertility in young girls. Then there’s the very serious gastrointestinal disorders, cancer and death. This is a vaccine which should be taken off the market, not extended to new mothers.
Gardasil is described as one the worst vaccines ever produced and responsible for more adverse events than any other. There are 30,000 videos on You Tube documenting the disaster and the ruined lives of young girls and now boys. Do those proposing to vaccinate young mothers have any idea how this vaccine might affect the infant? As well as containing the HPV antigens 6, 11, 16, 18, 31, 33, 45, 52, and 58, Gardasil 9 also contains 500 mcgs of aluminium adjuvant, yeast protein, L-histidine, polysorbate 80 and sodium borate. Polysorbate 80 and sodium borate have been linked to infertility in rats and therefore should not form part of any vaccine given to young women. Aluminium is a proven neurotoxin and once injected in the body can migrate and accumulate in the brain. Scientists at Keele University have recently discovered the way the aluminium in vaccine adjuvants travels from the site of injection to the brain. Another Gardasil additive L-histidine causes vasodilation and may be the reason for the common dangerous symptom of syncope or collapse experienced by many girls following Gardasil.
Gardasil and lactation
A search of Clinical Studies in Humans reveals that it is not known whether vaccine antigens or antibodies induced by the vaccine are excreted in human milk. This is clearly not very reassuring and this information should form part of any informed consent that young women are given.
Premature menopause and infertility
And what about the known effects of Gardasil on the reproductive system of girls and women which include premature menopause. Dr Deidre Little is an Australian doctor who questions the safety of the Gardasil vaccine. In the BMJ Case Reports authors Deidre Little and Harvey Rodrick Grenville Ward reported the case of a patient with amenorrhoea who had noticed that her usual regular menstrual cycle had changed, becoming irregular and then scant after her HPV vaccinations. The authors explain that it is very rare for the condition known as premature ovarian failure to occur at such an early age and that the annual incidence is 10 per 100,000 between 15 and 29 years of age. Premature ovarian failure is a serious health event for young girls and one that adversely affects their ability to have children.
Are these postpartum women informed of possible risks to their future ability to have children? This vaccine needs to be recalled, not trialled and marketed to more vulnerable people.
- In a trial sponsored by the National Institute of Child Health in Hungary, in collaboration with Merck, researchers are testing the 4-valent Gardasil vaccine in children to treat recurrent respiratory paillomatosis (RRP), a rare childhood disease caused by HPV
- Initially the study was to enroll children as young as 1 year old with RRP and administer three doses of HPV vaccine to “assess response to vaccination,” but recent study details indicate the tests are ongoing in children as young as 28 days old
- The study’s status remains unknown, as it has not yet been reported as completed